Published: Sat, February 23, 2019
Medical | By Vicki Mclaughlin

Young Blood Transfusions To Stop Aging Unproven And Potentially Harmful, FDA Warns

Young Blood Transfusions To Stop Aging Unproven And Potentially Harmful, FDA Warns

After the release of the FDA statement, however, the company posted the following statement on its site: "In compliance with the FDA announcement issued February 19, 2019, we have ceased patient treatments". In a statement, FDA commissioner Scott Gottlieb and Peter Marks, the director of the FDA's middle for Biologics Analysis and Analysis, cautioned "customers" (learn: "Nosferatu's dread offspring, the Vampyr, conductors of the symphony of the evening") towards "young donor plasma infusions" (learn: "young donor plasma infusions"). Therefore, these infusions shouldn't be considered safe or effective, and consumers shouldn't get the infusions beyond clinical trials with an institutional review board and regulatory oversight, it said. Plasma infusion is an approved use by the FDA in trauma settings or in patients whose blood doesn't coagulate.

Gottlieb mentioned that "a rising variety of clinics" are providing plasma from younger donors and related therapies, although he didn't identify any specifically.

Those claims, however - and any other information about Ambrosia Health - have been scrubbed from the website.

Plasma, or the liquid part of blood, is made up of proteins that help the blood clot.

In patients with certain types of cancer or chronic conditions, liver disease, and even severe burns, plasma can help save lives.

He said in an interview with The World-Herald last month that the yet-to-be published results of a clinical trial conducted by the company, which evaluated biomarkers of aging before and after treatment, found "real, objective improvements".

B.C. working on mandatory registration following measles outbreak
If no new cases of measles are reported by March 7, everyone will be allowed to return to school. The virus is spread through air-borne droplets after an infected person coughs or sneezes.

Amid Reports Of Attacks, Centre Asks States To Ensure Safety Of Kashmiris
States' police chiefs have been told to direct their officers to promptly take action on complaints. The court announced next Wednesday as the date of the next hearing.

Kraft Heinz fail leaves Buffett and 3G well fed
The company disclosed it received a subpoena from the Securities and Exchange Commission related to its accounting practices. JPMorgan analyst Ken Goldman said the entire strategy of 3G Capital to seek growth through cost cuts is now questionable.

While the USA blood supply and infusions of blood products are generally considered safe, there are known risks, including allergic reactions ranging from mild to life-threatening, lung injury, circulatory overload and new diseases that haven't yet been detected.

"We support sound, scientific research and regulation of medical treatments", Gottlieb and Marks said.

Some establishments, which call themselves "clinics", offer young blood infusions for as much as $8,000 a liter.

The agency hasn't approved plasma infusions for Alzheimer's disease, dementia, multiple sclerosis, Parkinson's disease, post‐traumatic stress disorder and heart disease, common conditions patients look to have treated.

He is concerned not only that the plasma itself may be harmful but that the "unproven purposes could also discourage patients suffering from serious or intractable illnesses from receiving safe and effective treatments that may be available to them". The two FDA officials said the agency had received reports of "bad actors" charging thousands of dollars for infusions.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices.

Like this: